Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• 18F-FDG (oral) (drug)
• 18F-FDG (intravenous) (drug)
• 18F-FET (oral) (drug)
• 18F-FET (intravenous) (drug)
• Glucagon (drug)
• Somatostatin (drug)
• Sodium chloride (placebo) (drug)
• Oral Glucose Tolerance Test (other)

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• Copenhagen University Hospital - Rigshospitalet
  Copenhagen, Denmark
  Site recruitment: Not reported

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• Tirzepatide (drug)
• Placebo (drug)

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• Brigham and Women's Hospital
  Boston, Massachusetts, United States
  Site recruitment: Not reported

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• Eloralintide and Tirzepatide (drug) — also listed as: LY3841136
• Eloralintide (drug) — also listed as: LY3841136

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• Anaheim Clinical Trials, LLC
  Anaheim, California, United States
  Site recruitment: Not reported
• Fortrea Clinical Research Unit
  Daytona Beach, Florida, United States
  Site recruitment: Not reported
• Fortrea Clinical Research Unit
  Dallas, Texas, United States
  Site recruitment: Not reported

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• Tirzepatide (drug)
• Semaglutide (drug)

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• Brigham and Women's Hospital
  Boston, Massachusetts, United States
  Site recruitment: Not reported

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• KAI-7535 (drug)

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• Anaheim Clinical Trials
  Anaheim, California, United States
  Site recruitment: Not reported

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• Tirzepatide (drug)
• Anti-Hypertensive medications (drug)

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• Cambridge University Hospitals NHS Foundation Trust
  Cambridge, Cambridgeshire, United Kingdom
  Site recruitment: Recruiting

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• Tirzepatide (drug)
• Placebo (drug)

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• Department of Endocrinology, Diabetes and Metabolic Diseases, University Medical Centre Ljubljana
  Ljubljana, Slovenia
  Site recruitment: Recruiting

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• Tirzepatide (Mounjaro) (drug) — also listed as: Dual GIP/GLP-1 receptor agonist
• dapagliflozin, empagliflozin, metformin (drug) — also listed as: Forxiga, Jardiance, Siofor

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• PI "National Laboratory Astana", Nazarbayev University
  Astana, Kazakhstan, Kazakhstan
  Site recruitment: Not reported

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• Liraglutide injection (drug)
• Diet and exercise guidelines (behavioral)

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• Nanjing Drum Tower Hospital
  Nanjing, China
  Site recruitment: Not reported

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• Stepped hyperinsulinaemic-hypoglycaemic clamp study (procedure)
• Insulin pump (device) — also listed as: Tandem t:slim x2 with Control IQ technology
• Continuous glucose monitor (device) — also listed as: Dexcom G6
• Low carbohydrate diet (other)
• Blinded continuous glucose monitor (device) — also listed as: Dexcom G6
• Stable isotope studies- D2 Glucose and D5 Glycerol (procedure)

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• Edinburgh Royal Infirmary/University of Edinburgh
  Edinburgh, United Kingdom
  Site recruitment: Not reported

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• Dulaglutide 0.75Mg/0.5Ml Inj Pen (drug)
• control group (insulin) (drug)

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• Faculty of medicine, Ain Shams University
  Cairo, Egypt
  Site recruitment: Not reported

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• GLP-1 (drug)

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• VA San Diego Healthcare System
  San Diego, California, United States
  Site recruitment: Not reported

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• GLP-1 hormone (other)
• Placebo (other)

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• Department of Endocrinology, University Hospital of Odense
  Odense, Denmark
  Site recruitment: Not reported

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• Tirzepatide (drug) — also listed as: GIP/GLP-1RA

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• DiaCenTRE - Hirslanden Clinique des Grangettes
  Chêne-Bougeries, Canton of Geneva, Switzerland
  Site recruitment: Recruiting
• Kantonsspital Olten
  Olten, Canton of Solothurn, Switzerland
  Site recruitment: Recruiting
• Luzerner Kantonspital
  Lucerne, Switzerland
  Site recruitment: Recruiting

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• Preoperative gastric ultrasound (other) — also listed as: Point-of-care gastric ultrasound (Gastric POCUS)

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• Wonkwang University Hospital
  Iksan, Jeollabuk-do, South Korea
  Site recruitment: Not reported
• Wonkwang University School of Medicine Hospital
  Iksan, Jeollabuk-do, South Korea
  Site recruitment: Not reported

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• Apitegromab (drug) — also listed as: SRK-015
• Placebo (drug)
• Tirzepatide (drug) — also listed as: ZEPBOUND

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• ProSciento CRU
  Chula Vista, California, United States
  Site recruitment: Not reported
• AdventHealth Translational Research Institute
  Orlando, Florida, United States
  Site recruitment: Not reported
• Great Lakes Clinical Trials, LLC d/b/a Flourish Research
  Chicago, Illinois, United States
  Site recruitment: Not reported
• Tandem Clinical Research GI, LLC
  Marrero, Louisiana, United States
  Site recruitment: Not reported
• Alliance for Multispecialty Research, LLC
  Norman, Oklahoma, United States
  Site recruitment: Not reported
• Apex Mobile Clinical Research
  Bellaire, Texas, United States
  Site recruitment: Not reported
• Clinical Trials of Texas, LLC dba Flourish Research
  San Antonio, Texas, United States
  Site recruitment: Not reported

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• GLP-1 analog (drug) — also listed as: GLP1 receptor agonist
• SGLT2 inhibitor (drug) — also listed as: gliflozin
• Antidiabetic (drug) — also listed as: Control

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

The registry does not list facilities in this record. This does not mean the study has no sites.

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• dual hormone fully closed loop (DHFCL) (device) — also listed as: Inreda AP (Inreda Diabetic BV)

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• Meander MC
  Amersfoort, Netherlands
  Site recruitment: Not reported
• Amsterdam UMC, AMC
  Amsterdam, Netherlands
  Site recruitment: Not reported
• Amsterdam UMC, VUmc
  Amsterdam, Netherlands
  Site recruitment: Not reported
• OLVG
  Amsterdam, Netherlands
  Site recruitment: Not reported
• Gelre Ziekenhuis
  Apeldoorn, Netherlands
  Site recruitment: Not reported
• Rijnstate
  Arnhem, Netherlands
  Site recruitment: Not reported
• Catharina Ziekenhuis
  Eindhoven, Netherlands
  Site recruitment: Not reported
• Martini Ziekenhuis
  Groningen, Netherlands
  Site recruitment: Not reported
• UMC Groningen
  Groningen, Netherlands
  Site recruitment: Not reported
• Tergooi Ziekenhuis
  Hilversum, Netherlands
  Site recruitment: Not reported
• LUMC
  Leiden, Netherlands
  Site recruitment: Not reported
• St. Antonius
  Nieuwegein, Netherlands
  Site recruitment: Not reported
• UMC Utrecht
  Utrecht, Netherlands
  Site recruitment: Not reported
• Isala Klinieken
  Zwolle, Netherlands
  Site recruitment: Not reported

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• Semaglutide (drug) — also listed as: GLP-1 RA, Semaglutide Injectable Product

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• University of Minnesota
  Minneapolis, Minnesota, United States
  Site recruitment: Not reported